WANY
INSP icon

Wealthspire Advisors (New York)’s Inspire Medical Systems INSP Stock Holding History

Wealthspire Advisors (New York)’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,882
Closed -$266K – 1018
2025
Q4 		$266K Sell
2,882
-1,298
-31% -$124K ﹤0.01% 857
2025
Q3 		$310K Sell
4,180
-68
-2% -$6.88K ﹤0.01% 653
2025
Q2 		$551K Buy
4,248
+42
+1% +$6.09K ﹤0.01% 514
2025
Q1 		$670K Buy
4,206
+2,036
+94% +$368K ﹤0.01% 457
2024
Q4 		$402K Buy
+2,170
New +$421K ﹤0.01% 574

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wealthspire Advisors (New York)'s INSP Position: Q1 2026 in Review

Wealthspire Advisors (New York) sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 2,882 shares — an estimated $266K sold.

Wealthspire Advisors (New York) first reported a position in INSP in Q4 2024 and held it in 5 quarters. The position peaked at $670K in Q1 2025. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • Wealthspire Advisors (New York) reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 2,882 Inspire Medical Systems shares in Q1 2026, an estimated $266K.
  • Wealthspire Advisors (New York) first reported a position in Inspire Medical Systems in Q4 2024 and held it in 5 quarters.
  • Wealthspire Advisors (New York)'s Inspire Medical Systems position peaked at $670K in Q1 2025.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.